Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20262 analyst targets · 90 days
- Share price
- $21.62
- Average 1Y price target
- $24.75+14.48%
- Agreement
- Fair
Analysts agreement range is spread 15% to 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall1
- DCF2
- Return on equity1
- Return on assets1
- Debt / equity2
- P/E1
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 2 | $30.00 |
| Last quarter | 5 | $23.20 |
| Last year | 9 | $18.56 |
| All time | 23 | $24.35 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Leerink Partners | maintain | Outperform | Outperform |
| Aug 26, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Aug 7, 2026 | Wedbush | upgrade | Neutral | Outperform |
| Aug 7, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Aug 4, 2026 | Leerink Partners | upgrade | Market Perform | Outperform |
| Jul 31, 2026 | Wedbush | maintain | Neutral | Neutral |
| Jul 31, 2026 | Cantor Fitzgerald | upgrade | Neutral | Overweight |
| Jun 30, 2026 | Wedbush | maintain | Neutral | Neutral |
| Jun 26, 2026 | JP Morgan | upgrade | Neutral | Overweight |
| Jun 1, 2026 | Wedbush | maintain | Neutral | Neutral |
| May 29, 2026 | JP Morgan | upgrade | Underweight | Neutral |
| Apr 13, 2026 | Wedbush | downgrade | Outperform | Neutral |
| Apr 13, 2026 | Leerink Partners | downgrade | Outperform | Market Perform |
| Apr 13, 2026 | JP Morgan | downgrade | Neutral | Underweight |
| Apr 13, 2026 | Jefferies | downgrade | Buy | Hold |
| Apr 13, 2026 | HC Wainwright & Co. | downgrade | Buy | Sell |
| Apr 13, 2026 | Cantor Fitzgerald | downgrade | Overweight | Neutral |
| Feb 5, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Feb 4, 2026 | Wedbush | maintain | Outperform | Outperform |
| Nov 3, 2025 | BMO Capital | upgrade | Underperform | Market Perform |
| Oct 27, 2025 | HC Wainwright & Co. | upgrade | Neutral | Buy |
| Oct 20, 2025 | Wedbush | upgrade | Neutral | Outperform |
| Oct 20, 2025 | Leerink Partners | upgrade | Market Perform | Outperform |
| Oct 20, 2025 | JP Morgan | upgrade | Underweight | Neutral |
| Sep 19, 2025 | JP Morgan | downgrade | Neutral | Underweight |
| Sep 8, 2025 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| Jul 30, 2025 | Cantor Fitzgerald | upgrade | Neutral | Overweight |
| Jul 23, 2025 | HC Wainwright & Co. | downgrade | Buy | Neutral |
| Jul 23, 2025 | BMO Capital | downgrade | Outperform | Underperform |
| Jul 23, 2025 | Barclays | downgrade | Overweight | Equal Weight |
| Jul 22, 2025 | Wedbush | downgrade | Outperform | Neutral |
| Jul 22, 2025 | Leerink Partners | downgrade | Outperform | Market Perform |
| Jul 22, 2025 | JP Morgan | downgrade | Overweight | Neutral |
| Jul 22, 2025 | Jefferies | maintain | Buy | Buy |
| Jul 16, 2025 | JP Morgan | maintain | Overweight | Overweight |
| Jul 3, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jun 2, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Feb 26, 2025 | JP Morgan | maintain | Overweight | Overweight |
| Feb 13, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jan 22, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |